Diag-Nose Medical
Latest round
- Seed
Last raised
- Jan 2025
Total raised
- $3.1M
Investors
- 2
About Diag-Nose Medical
Founded in 2020 and based in Australia, Diag-Nose Medical Pty Ltd focuses on respiratory diagnostics and therapeutics. Eldin Rostom (CEO), Dr. David Yen, Dr. Josie Xu, and Dr. Brian Wang, founded the firm. Diag-Nose Medical offers solutions for respiratory care, focusing on the relationship between the lungs and nasal passages. The company's core offering includes advanced immune diagnostics and therapies tailored for respiratory patients, utilizing an AI-driven approach to match individuals with appropriate drug treatments based on their biological makeup. This precision medicine framework aims to support respiratory treatments by decoding the underlying biology of the immune system and utilizing biomarkers to guide therapy selection. Diag-Nose targets a diverse client base that includes healthcare providers, research institutions, and pharmaceutical partners, aiming to serve patients globally, particularly in markets such as Australia and the United States. Diag-Nose Medical generates revenue through a structured model that emphasizes partnerships with healthcare providers and research organizations, allowing for direct access to patients and clinical data. The company engages in B2B transactions, wherein healthcare institutions subscribe to its diagnostic services or collaborate on research initiatives. The pricing structure reflects the advanced technology and research underpinning its offerings, encompassing fees for personalized diagnostic assessments and the development of bespoke therapeutic solutions. The company aims to expand its market presence further into the Australian and US healthcare sectors while exploring additional global markets.
Who invested in Diag-Nose Medical
2 investors across 1 round
See all investors in Diag-Nose Medical
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 29, 2025
Amount
$3.1M
Investors
Questions about Diag-Nose Medical
Who invested in Diag-Nose Medical?
Diag-Nose Medical has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Diag-Nose Medical raised?
Diag-Nose Medical has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Diag-Nose Medical last raise money?
Diag-Nose Medical's most recent round on record is a Seed, in Jan 2025.
What does Diag-Nose Medical do?
Founded in 2020 and based in Australia, Diag-Nose Medical Pty Ltd focuses on respiratory diagnostics and therapeutics.
Where is Diag-Nose Medical headquartered?
Diag-Nose Medical is headquartered in Port Melbourne, Australia.
Which VCs invest in companies like Diag-Nose Medical?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back biotechnology companies at Diag-Nose Medical's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Diag-Nose Medical? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.